RPg Family Wealth Advisory LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 90 shares of the medical equipment provider’s stock, valued at approximately $44,000.
Several other large investors have also recently made changes to their positions in the company. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. LGT Financial Advisors LLC grew its holdings in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Stock Down 0.7 %
Intuitive Surgical stock opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00. The company’s 50 day moving average is $507.94 and its two-hundred day moving average is $466.79. The firm has a market cap of $191.82 billion, a PE ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $526.06.
View Our Latest Stock Analysis on Intuitive Surgical
Insiders Place Their Bets
In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,459 shares of company stock valued at $26,080,251 in the last ninety days. Insiders own 0.80% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Golden Cross Stocks: Pattern, Examples and Charts
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Profitably Trade Stocks at 52-Week Highs
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Canada Bond Market Holiday: How to Invest and Trade
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.